Abstract:Glucocorticoids have significant anti-inflammatory effects, which are widely used to treat chronic airway inflammatory diseases, including allergic rhinitis, chronic rhinosinusitis, asthma and chronic obstructive pulmonary disease. Glucocorticoids can bind to intranuclear glucocorticoid receptors (GR), pass through the nuclear pores, and then exert physiological effects by regulating the expression of related genes in the nucleus. However, some patients with long-term use of glucocorticoids have poor efficacy or even ineffectiveness, that is, the corticosteroid resistance (CR) phenomenon. CR affects the therapeutic effect of glucocorticoids, which will lead to the persistence of an inflammatory state. Therefore, understanding the mechanism of CR is crucial for guiding the treatment of the diseases. The mechanisms of CR are similar to some extent in different types of chronic airway inflammatory diseases. Recent studies suggest that the occurrence of CR is closely related to the changes (such as gene expression, affinity, gene polymorphism, etc.) in GR. In this paper, the therapeutic mechanism of glucocorticoids was briefly reviewed, and the research progress on the mechanism of CR related to receptors was reviewed.